Five questions to better understand T-cell receptors therapy
T-Cell receptors therapy is a growing area of immuno-oncology with recent breakthroughs in clinical settings, thereby demonstrating his therapeutic potential in mitigating tumor development. So what do you know about T-Cell therapy? Read on! Dr. Erika von Euw from T-Cure Bioscience help us to understand it better.
Research Roundup: cell biology
Do you love cell biology? Here for you are three new research studies showing our antibodies in action. This latest Research Roundup talks about kinesin’s motor domain in microtubules, membranes & trafficking in organelles, and lysosomal protein composition.
Ion channels as promising biomarkers in cancer
In this blog post, we share bits of evidence about the involvement of voltage-gated ion channels in human cancers, highlighting their promising use as biomarkers. Read on!
Interview with a scientist: proteomics, biomarkers and ALS.
No effective therapies are currently available for Amyotrophic Lateral Sclerosis- ALS due to the lack of biomarkers for early diagnosis and monitoring disease progression. Dr. Valentina Bonetto applies proteomic assays to find validated biomarkers and innovative therapeutic strategies to treat ALS.
4 things I missed during the Society for Neuroscience virtual conference…or did I?
The Society for Neuroscience, SfN, holds an annual meeting that is attended by scientists and physicians from all around the world. This year, because of the ongoing pandemic, the meeting was run virtually. Did I enjoy it?
Two-years blog anniversary! A recap of our most popular posts
This month we celebrate the second birthday of our blog. If you have missed it read on. Here is a recap just for you.
How Enhanced Validation helps you publish your research
Do you know what to expect from a good antibody? How and when an antibody meets your expectations? Have you ever heard about enhanced validation? Read on to know more about it!
Interview with a scientist: traffic jams at the nuclear pores
Within our body, hundreds of molecules pass in and out across the cellular membranes, and, similarly to cars, they can get stuck in traffic jams. This nuclear-cytoplasmic trafficking might contribute to neurological disorders. Read more and learn about Dr. Rita Sattler's research.
Interview with a scientist: drug repurposing in oncology
Drug repurposing is the strategy of using existing drugs originally developed for a specific disease to treat other diseases. We have interviewed Dr. Joanna Zawacka-Pankau about her research in drug repurposing to treat cancer.
Now I see you: the imaging toolbox that improves the detection of primary ciliary dyskinesia
Ciliopathies are inherited human disorders that affect primary cilia genes. The authors of this study took part in our Explorer Program. Read on to discover what they found.